Sunrise’s At-Home Sleep Apnea Test Gets FDA Clearance

Belgium-based digital health scale-up Sunrise announced it has received clearance from the US Food and Drug Administration (FDA) for its second generation at-home sleep apnea test.

The artificial intelligence (AI)-powered device, referred to as the Sunrise Sleep Disorder Diagnostic Aid (SDDA), can help diagnose sleep conditions like obstructive sleep apnea and sleep-related breathing disorders.